Clinical trials are often presented as perfect equations: endpoints, randomization, inclusion criteria. But in real life, research moves across a much more complex terrain, the terrain of people: patients, caregivers, physicians, nurses, research teams. All with expectations, fears and very real constraints. This is precisely where the human factor becomes decisive.
Ignoring it means risking well-known issues such as slow recruitment, drop-outs and incomplete data. A protocol may be methodologically flawless on paper, but without the perspective of those who take part, the results risk remaining purely theoretical.
Integrating the human factor does not reduce scientific rigor, we could even argue that it strengthens it. Endpoints that reflect patients’ priorities improve adherence. Streamlined procedures, more flexible visits and intuitive digital tools enhance data quality. Science does not lose precision by becoming more human; it simply becomes (so to speak) more aligned with real life.
There is also an ethical dimension, often overlooked. Involving patients in study design, listening to their priorities, testing informational materials and assessing the impact on daily life are acts of responsibility and awareness.
Participating in a trial requires time, energy and trust.
Today, in a world that speaks of patient centricity and value-based research, the human factor cannot remain a detail. It must become an integral part of study design, considered with the same level of attention given to regulations and statistical analyses. Perhaps the real question is not how much it matters, but how much we can afford to overlook it.